Moderate hypofractionation for prostate cancer with fiducials markers

被引：0
|
作者：
Molina Osorio, J. G. [1 ]
Meca Santamaria, G. [1 ]
Villalobos Monardes, M. [1 ]
Moreno Lopez, S. [1 ]
Ballester Alabau, R. [1 ]
Alvarez Gracia, A. [1 ]
Comas Anton, S. [1 ]
Jove Teixido, J. [1 ]
Caro Gallarin, M. [1 ]
Prats Cabeces, L. [2 ]
Luguera Sanchez, E. [2 ]
Molero Savall, J. [2 ]
Villa Freixa, S. [1 ]
机构：
[1] Inst Catala Oncol, Radiat Oncol, Badalona, Spain
[2] Inst Catala Oncol, Med Phys, Badalona, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1382
引用
收藏
页码：S1171 / S1172
页数：2
相关论文
共 50 条
  • [1] Moderate hypofractionation for prostate cancer
    Arcangeli, Stefano
    Arcangeli, Giorgio
    ONCOTARGET, 2017, 8 (49) : 84612 - 84613
  • [2] Moderate hypofractionation for prostate cancer
    Lee, W. Robert
    Koontz, Bridget F.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 321 - 329
  • [3] Moderate hypofractionation for prostate cancer: A user's guide
    Pryor, David I.
    Turner, Sandra L.
    Tai, Keen Hun
    Tang, Colin
    Sasso, Giuseppe
    Dreosti, Marcus
    Woo, Henry H.
    Wilton, Lee
    Martin, Jarad M.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2018, 62 (02) : 232 - 239
  • [4] Risk-adapted moderate hypofractionation of prostate cancer
    Schoerghofer, Andreas
    Groher, Michael
    Karner, Josef
    Kopp, Andrea
    Kametriser, Gerhard
    Kunit, Thomas
    Holzinger, Josef
    Sedlmayer, Felix
    Wolf, Frank
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (10) : 894 - 901
  • [5] Dose constraints validation in moderate hypofractionation in localized prostate cancer
    Maldonado, X.
    Altabas, M.
    Garre, J.
    Vazquez, M.
    Magrina, S.
    Delgado, A.
    Docampo, N.
    Geng, A.
    Hermida, M.
    Sanchez-Artuno, D.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1113 - S1114
  • [6] Moderate or extreme hypofractionation and localized prostate cancer: The times are changing
    Krhili, S. Line
    Crehange, G.
    Albert-Dufrois, H.
    Guimas, V.
    Minsat, M.
    Supiot, S.
    CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 503 - 509
  • [7] Toxicity Profile in Postoperative Radiotherapy for Prostate Cancer with Moderate Hypofractionation
    Pacifico, P.
    Bonetto, E. M.
    Niespolo, R. M.
    De Ponti, E.
    Vukcaj, S.
    Arcangeli, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S610 - S610
  • [8] Moderate hypofractionation radiotherapy with helical tomotherapy (HT) for prostate cancer
    Ferrera, G.
    Mortellaro, G.
    Caminiti, G.
    Mazzola, R.
    Spera, A.
    Grillo, A.
    Di Paola, G.
    Cucchiara, T.
    Sciume, F.
    Messana, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S91 - S92
  • [9] Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer
    Beckta, Jason M.
    Nosrati, Jason D.
    Yu, James B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 619 - 627
  • [10] Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer
    Laughlin, Brady S.
    Anderson, Justin D.
    Hobbis, Dean
    Armstrong, Michael
    Vargas, Carlos E.
    Rong, Yi
    Yu, Nathan Y.
    BJU INTERNATIONAL, 2023, 132 (06) : 648 - 650
12345